RCUS
Arcus Biosciences Inc

1,784
Mkt Cap
$2.6B
Volume
1M
52W High
$26.40
52W Low
$6.50
PE Ratio
-6.31
RCUS Fundamentals
Price
$21.66
Prev Close
$21.04
Open
$21.00
50D MA
$23.05
Beta
1.44
Avg. Volume
1.36M
EPS (Annual)
-$3.14
P/B
5.32
Rev/Employee
$411,483.25
Loading...
Loading...
News
all
press releases
Arcus Biosciences Announces New Employment Inducement Grants
Arcus Biosciences, Inc. (NYSE:RCUS), a clinical-stage, global biopharmaceutical company focused on developing differentiated molecules and combination therapies for people with cancer and...
Business Wire·7d ago
News Placeholder
More News
News Placeholder
Arcus Biosciences, Inc. (NYSE:RCUS) Sees Significant Increase in Short Interest
Arcus Biosciences, Inc. (NYSE:RCUS - Get Free Report) was the recipient of a significant growth in short interest during the month of December. As of December 31st, there was short interest totaling...
MarketBeat·14d ago
News Placeholder
Arcus Biosciences (NYSE:RCUS) Upgraded to "Hold" at Wall Street Zen
Wall Street Zen upgraded Arcus Biosciences from a "sell" rating to a "hold" rating in a research report on Sunday...
MarketBeat·16d ago
News Placeholder
Arcus Biosciences (NYSE:RCUS) Trading Down 5.8% - Time to Sell?
Arcus Biosciences (NYSE:RCUS) Trading Down 5.8% - Should You Sell...
MarketBeat·18d ago
News Placeholder
Arcus Biosciences (NYSE:RCUS) Shares Gap Down on Insider Selling
Arcus Biosciences (NYSE:RCUS) Shares Gap Down After Insider Selling...
MarketBeat·26d ago
News Placeholder
Arcus Biosciences President Sells $2 Million as Stock Delivers 48% Annual Return
Key Points82,997 shares were sold indirectly on Dec. 4, 2025, for a transaction value of ~$2.1 million based on a weighted average sale price of $24.71 per share...
Nasdaq News: Markets·28d ago
News Placeholder
Arcus Biosciences (NYSE:RCUS) Trading Down 7.8% Following Insider Selling
Arcus Biosciences (NYSE:RCUS) Shares Down 7.8% After Insider Selling...
MarketBeat·29d ago
News Placeholder
Insider Selling: Arcus Biosciences (NYSE:RCUS) CFO Sells 6,552 Shares of Stock
Arcus Biosciences, Inc. (NYSE:RCUS - Get Free Report) CFO Robert Goeltz II sold 6,552 shares of the business's stock in a transaction dated Wednesday, December 31st. The shares were sold at an...
MarketBeat·1mo ago
News Placeholder
Arcus Biosciences (NYSE:RCUS) Trading Up 2.8% - Should You Buy?
Arcus Biosciences (NYSE:RCUS) Stock Price Up 2.8% - Time to Buy...
MarketBeat·1mo ago
News Placeholder
Squarepoint Ops LLC Boosts Stake in Arcus Biosciences, Inc. $RCUS
Squarepoint Ops LLC lifted its stake in shares of Arcus Biosciences, Inc. (NYSE:RCUS - Free Report) by 163.7% in the second quarter, according to its most recent filing with the SEC. The fund owned...
MarketBeat·1mo ago
<
1
2
...
>

Latest RCUS News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.